Government Gazette Staatskoerant

Similar documents
Government Gazette Staatskoerant

Government Gazette Staatskoerant

REPUBLIC OF SOUTH AFRICA

Government Gazette Staatskoerant

Government Gazette Staatskoerant

WMA Declaration of Helsinki Ethical Principles f or Medical Research Involving Human Subjects

Government Gazette Staatskoerant

DEPARTMENT OF ENVIRONMENTAL AFFAIRS. No May 2014 NATIONAL ENVIRONMENTAL MANAGEMENT: WASTE ACT, 2008 (ACT NO. 59 OF 2008)

DEPARTMENT OF ENVIRONMENTAL AFFAIRS. No November 2013 NATIONAL ENVIRONMENTAL MANAGEMENT: WASTE ACT, 2008 (ACT NO.

WMA Declaration of Helsinki - Ethical

World Medical Association Declaration of Helsinki

Ethical Principles in Clinical Research

AIDS HEIRINE Prevention is the cure. We oil hawm he power to preftvent klldc EXTRAORDINARY BUITENGEWONE. No NORTHERN CAPE PROVINCE

Government Gazette Staatskoerant

PROTOCOL DRAFTING GUIDE

Government Gazette Staatskoerant

AIDS HEIRINE Prevention is the cure. We oil hawm he power to preftvent klldc NORTHERN CAPE PROVINCE IPHONDO LOMNTLA KOLONI

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland

EIGHT BASIC ELEMENTS OF INFORMED CONSENT

Institutional Review Board Compliance Elizabeth City State University

Institutional Review Board

What is an IRB (Institutional Review Board)?

Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center

1 oaoo o IIIII I 111m IIIIIIIIIIIUII AIDS HELPUNE. Prevention is the cure. We all have the power to prevent AIDS

Research: Ethics, Informed Consent, FDA, Off Label Use

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience

For the purposes of this document, the above statement should be used to guide the reader s understanding of health research.

Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

Rules of Human Experimentation

MEDICINES CONTROL COUNCIL

UNIVERSITY OF GEORGIA Institutional Review Board

A notice on the issuance of drug clinical trials, ethical review of the guiding principles

RSC/CT Det. no. 1/2013

Child and Family Agency. Research Ethics Committee Guidelines

MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155

Protection of Research Participants: The IRB Process and the Winds of Change

Volunteering for Clinical Trials

Florida State University Policy 7-IRB-

4-6 Peel Street North, Ballarat. General Manager, Employment Services & Centacare Housing. Labour Market Industry Award

S A I N T M A RY S E M I N A RY O C T O B E R 1 9,

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

MEDICINES AND RELATED SUBSTANCES ACT, (ACT NO. 101 OF 1965) the Regulations Relating to a Transparent Pricing System for Medicines and Scheduled

WCG ACADEMY COURSE OVERVIEW

SKILLS DEVELOPMENT ACT, 1998 (ACT NO. 97 of 1998) LEARNERSHIP REGULATIONS, 2007

Independent Living Needs and Risk Assessment Policy

Department of Institutional Research and Planning. Survey Policy

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)

Sponsorship of Clinical Research Studies

Institutional Review Board (IRB)

Audit report VET Quality Framework

Standard Operating Procedure: Obtaining Informed Consent from Competent Adults for Research Studies. SOP Number: UoA-NHSG-SOP-010 Version No: 2

Practising Certificate Training Record (PCTR) GLOBAL edition

Ethics Procedures ETHICAL ISSUES

Research Governance Policy and Procedure

Expedited Review of Human Subject Research

Office for Human Subject Protection. University of Rochester

Data Protection Policy

APPLICANT'S CHECKLIST

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

POLICY ON RESEARCH ETHICS

The Salvation Army Northern Division Volunteer Policies & Procedures A. GENERAL POLICIES & PROCEDURES

ANNEX. CHAPTER I General principles

Practising Certificate Training Record (PCTR) UNITED KINGDOM, REPUBLIC OF IRELAND AND CYPRUS EDITION

APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1

Agenzia Italiana del Farmaco

The Intersection of Genomics Research and the IDE Regulation

Information Governance Policy

CODE OF PRACTICE FOR RESEARCH

Review PROCESS, decision making PROCESS and communication BY

Clinical Trials Management for Molecular Diagnostics. April 2016

Work Placement Handbook for Graduate Diploma in New Zealand Immigration Advice

Institutional Review Board for Use of Human and Animal Subjects in Research OIT

Supplier Code of Conduct

Human Research Protection Program Guidance for Human Research Determination

University-wide. Staff Only Students Only Staff and Students. Vice-Chancellor. Chief Operating Officer. Director, Human Resources

HUGO BOSS Social Standards

Competent federal higher authority ("Bundesoberbehörde- BOB")

Data Protection Policy

Assistant Manager, Social Work (New position)

IRB-GCP and Timelines. Andrew Majewski, MSc. 1 st DOLF Meeting Washington University School of Medicine St Louis, Missouri-USA October th, 2010

Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE

Auditing of Swedish Enterprises and Organisations

JOB POSTING. Position Overview. Key Responsibilities. Start Date: June 1, 2018 End Date: May 31, 2019 Posting Period: March 21 to April 03, 2018

ADMINISTRATIVE PROCEDURE

Data Protection Policy

MEDICAL COUNCIL OF NEW ZEALAND

Ethical, Legal and Social Issues arising out of Advancements in New Biology. Seyed E. Hasnain

Clinical trial information leaflet and consent

Regulatory and ethical requirements in medical device studies. Finland

HOSPITAL AUTHORITY (HA) GUIDE

Ethics and Clinical trials EU approach

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor.

REQUEST FOR PROPOSAL. HRIS Human Resources Information Software Fort Morgan, Colorado

Government Notices Goewermentskennisgewings

WUNGENING ABORIGINAL CORPORATION

The Hotelbeds Group Supplier Code of Conduct. Guidance for suppliers to Hotelbeds Group and its subsidiaries ( Hotelbeds Group )

Investigator Manual. Human Subjects Protection Program

VOLUNTEER SERVICE COORDINATOR. Central Victorian Volunteer Service. EFT 0.6 (3 days per week)

Transcription:

Government Gazette Staatskoerant REPUBLIC OF SOUTH AFRICA REPUBLIEK VAN SUID-AFRIKA Regulation Gazette No. 10268 Regulasiekoerant Vol. 591 Pretoria, 19 September 2014 No. 38000 N.B. The Government Printing Works will not be held responsible for the quality of Hard Copies or Electronic Files submitted for publication purposes AIDS HELPLINE: 0800-0123-22 Prevention is the cure 403354 A 38000 1

2 No. 38000 GOVERNMENT GAZETTE, 19 SEPTEMBER 2014 IMPORTANT NOTICE The Government Printing Works will not be held responsible for faxed documents not received due to errors on the fax machine or faxes received which are unclear or incomplete. Please be advised that an OK slip, received from a fax machine, will not be accepted as proof that documents were received by the GPW for printing. If documents are faxed to the GPW it will be the sender s responsibility to phone and confirm that the documents were received in good order. Furthermore the Government Printing Works will also not be held responsible for cancellations and amendments which have not been done on original documents received from clients. CONTENTS INHOUD No. Page No. Gazette No. No. Bladsy No. Koerant No. GOVERNMENT NOTICE Health, Department of Government Notice R. 719 National Health Act (61/2003): Regulations relating to research with human participants... 4 38000 GOEWERMENTSKENNISGEWING Gesondheid, Departement van Goewermentskennisgewing R. 719 National Health Act (61/2003): Regulations relating to research with human participants... 4 38000

STAATSKOERANT, 19 SEPTEMBER 2014 No. 38000 3 IMPORTANT ANNOUNCEMENT GOVERNMENT NOTICES, GENERAL NOTICES, REGULATION NOTICES AND PROCLAMATIONS Closing times PRIOR TO PUBLIC HOLIDAYS for The closing time is 15:00 sharp on the following days: 2014 18 September, Thursday, for the issue of Friday 26 September 2014 11 December, Thursday, for the issue of Friday 19 December 2014 15 December, Monday, for the issue of Wednesday 24 December 2014 19 December, Friday, for the issue of Friday 2 January 2015 Late notices will be published in the subsequent issue, if under special circumstances, a late notice is accepted, a double tariff will be charged The copy for a SEPARATE Government Gazette must be handed in not later than three calendar weeks before date of publication BELANGRIKE AANKONDIGING Sluitingstye VOOR VAKANSIEDAE vir GOEWERMENTS-, ALGEMENE- & REGULASIE- KENNISGEWINGS ASOOK PROKLAMASIES Die sluitingstyd is stiptelik 15:00 op die volgende dae: 2014 18 September, Donderdag, vir die uitgawe van Vrydag 26 September 2014 11 Desember, Donderdag, vir die uitgawe van Vrydag 19 Desember 2014 15 Desember, Maandag, vir die uitgawe van Woensdag 24 Desember 2014 19 Desember, Vrydag, vir die uitgawe van Vrydag 2 Januarie 2015 Laat kennisgewings sal in die daaropvolgende uitgawe geplaas word. Indien n laat kennisgewing wel, onder spesiale omstandighede, aanvaar word, sal n dubbeltarief gehef word Wanneer n APARTE Staatskoerant verlang word moet die kopie drie kalenderweke voor publikasie ingedien word

4 No. 38000 GOVERNMENT GAZETTE, 19 SEPTEMBER 2014 GOVERNMENT NOTICE GOEWERMENTSKENNISGEWING DEPARTMENT OF HEALTH DEPARTEMENT VAN GESONDHEID No. R. 719 19 September 2014 NATIONAL HEALTH ACT, 2003 (ACT NO. 61 OF 2003) REGULATIONS RELATING TO RESEARCH WITH HUMAN PARTICIPANTS The Minister of Health has, in terms of Section 71 read with Section 90(1) of the National Health Act, 2003 (Act No. 61 of 2003) made the Regulations in the schedule. SCHEDULE Definitions 1. In these regulations "the Act" means the National Health Act (Act No. 61 of 2003), and any word or expression to which a meaning has been assigned in the Act, shall bear that meaning, unless the context indicates otherwise- "best interests" means significant decisions affecting a minor's life should aim to promote, amongst others, the minor's physical, mental, moral, emotional and social welfare; "condition" means physical and psycho-social characteristics understood to affect health; "Council" means the National Health Research Ethics Council established under Section 72 of the Act;

STAATSKOERANT, 19 SEPTEMBER 2014 No. 38000 5 "health research ethics committee" means any committee registered in terms of Section 73 of the Act; "human participant" means a living person about whom a researcher obtains data or specimens or identifiable private information through intervention or interaction with that person; "Medicines Control Council" means the Medicines Control Council established in terms of Section 2 of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965) or its successor in title; "minimal risk" means the probability and magnitude of harm or discomfort anticipated in the research is not greater than that ordinarily encountered in daily life in a stable society or in routine medical, dental, educational or psychological tests or examinations; "non-therapeutic research" means research that does not hold out the prospect of direct benefit to the participant but holds out the prospect of generalizable knowledge; "significant risk" means substantial risk of serious harm; "therapeutic research" means research that holds out the prospect of direct benefit to the participant; "vulnerable persons" means those persons at increased risk of research-related harm, or who are limited in their freedom to make choices, or relatively incapable of protecting their own interests.

6 No. 38000 GOVERNMENT GAZETTE, 19 SEPTEMBER 2014 Principles guiding research with human participants 2. Health research that involves human participants must- (a) comply with the Department of Health national ethical guidelines for research with human participants at a minimum; be responsive to health needs or priorities of the population, participating community or proposed participants; (c) have a valid scientific methodology and be likely to provide answers for the specific research questions that are posed; (d) include a favourable risk-benefit analysis; (e) ensure that the recruitment and selection process is just and fair; (f ) be undertaken with appropriate consent processes; (g) undergo independent review by a registered health research ethics committee; (h) respect participants' rights, including but not limited to rights to dignity, privacy, bodily integrity and equality; (i) make provision for compensation for research-related injury, for more than minimal risk research; and (j) be managed by a lead researcher, or person with similar standing or title, with suitable experience and qualifications.

STAATSKOERANT, 19 SEPTEMBER 2014 No. 38000 7 Obligations of researchers who conduct research with human participants 3. A researcher who conducts health research involving human participants must- (a) submit the research proposal for ethics review and approval to a registered health research ethics committee and, where applicable, to the Medicines Control Council or any other body required by law, before commencing with the research; consult with representatives from the participating community or other relevant research stakeholders, where appropriate; (c) consult with and notify the affected institutional or governmental authorities where necessary; (d) assess the ongoing welfare of participants and take appropriate steps in the event that participants experience harms; (e) disseminate research results, whether negative or positive, to research stakeholders, in a timely and competent manner including to participants and participating communities as far as possible; and (f) register the research in the South African National Clinical Trials Register, if classified as a clinical trial. Research with human participants who are vulnerable 4. Research with vulnerable persons must - (a) involve vulnerable persons only when non-vulnerable persons are not appropriate for inclusion;

8 No. 38000 GOVERNMENT GAZETTE, 19 SEPTEMBER 2014 not systematically avoid inclusion of vulnerable participants because to do so is unfairly discriminatory and vulnerable persons are potential beneficiaries of relevant research; (c) be responsive to the health needs and the priorities of vulnerable persons; and (d) receive special attention in ethical review to ensure that research-related risks are assessed and minimized and that appropriate consent procedures are followed. 4.1 Research with minors should only take place when - (a) adults are not appropriate participants for the research; the research poses no more than a minimal risk to the minor; or (c) the research poses more than a minimal risk, but holds out the prospect of direct benefit to the minor; or (d) the research poses a minor increase over minimal risk, and holds out no prospect of direct benefit to the minor, but is anticipated to yield generalizable knowledge about the condition under study. 4.2 Research with adults with decision-making incapacity is appropriate when - (a) the research cannot be conducted with adults who have decision-making capacity; the research poses no more than a minimal risk; or

STAATSKOERANT, 19 SEPTEMBER 2014 No. 38000 9 (c) the research poses more than a minimal risk, but holds out the prospect of direct benefit to the participant; or (d) the research poses a minor increase over minimal risk, and holds out no prospect of direct benefit but is anticipated to yield generalizable knowledge about the condition under study. 4.3 Research with prisoners is appropriate when - (a) the risk of harm posed by the research is commensurate with risks that would be accepted by non-prisoner volunteers; the rights of prisoners, including but not limited to the rights to dignity, privacy, bodily integrity and equality, will be protected; and (c) the procedures and guidelines issued by the Department of Correctional Services will be followed. 4.4 Research with persons in dependent or hierarchical relationships - (a) includes but is not limited to research with users and their health-care workers; persons with life-threatening diseases and their care-givers, wards of the state and their guardians or care-givers, employees and their employers, prisoners and the relevant prison authorities and members of the national defence force and their superiors; and is appropriate when research-related risks of harm are minimized, and appropriate consent procedures have been followed.

10 No. 38000 GOVERNMENT GAZETTE, 19 SEPTEMBER 2014 Informed Consent for research with human participants 5. Human participants, or their legally authorised representatives, must be informed of - (a) the purpose of the research; the methods and procedures, including possible randomisation; (c) alternatives to participation in the research; (d) the potential harms and risks of harm posed by the research; (e) the expected benefits of the research; (f) the freedom to choose to participate or not, or to withdraw from the research without penalty or reason; (g) the extent to which confidentiality and privacy will be maintained; (h) details of the contact person in the event of a query or research-related injury; (i) reimbursement and/or incentives given for participation; (j) information about the sponsor; (k) any potential conflict of interests; (I) information about approval from the health research ethics committee or the Medicines Control Council, where relevant;

STAATSKOERANT, 19 SEPTEMBER 2014 No. 38000 11 (m) insurance in the event of research-related injury, for more than minimal risk research; and (n) the availability of beneficial products or interventions post-research. Review of proposals for research with human participants 6. All health research proposals involving human participants must- (a) be reviewed by a health research ethics committee which is registered with the Council; satisfy the requirements as set out in the Department of Health's national ethical guidelines for research with human participants at a minimum and any additional standards as determined by the health research ethics committee; and (c) adhere to the decisions made by the health research ethics committee. Ministerial consent for non-therapeutic research with minors 7. Protocols for human participants' research that propose non-therapeutic research with minors must have ministerial consent in terms of Section 71(3)(a)(ii) of the Act or, where appropriate, consent from a delegated authority in terms of Section 92(a) of the Act. (a) Applications for ministerial consent must be made on Form A; the application should be considered by the Minister or the delegated authority after the protocol is reviewed by a registered health research

12 No. 38000 GOVERNMENT GAZETTE, 19 SEPTEMBER 2014 ethics committee to assess whether it meets the required norms and standards of the health research ethics committee; (c) in granting ministerial consent, relevant bodies or experts may be consulted; (d) the researcher must be notified of the outcome in writing within 60 days; and (e) the researcher may appeal the outcome including by approaching the National Health Research Ethics Council in terms of Section 72 (6) (d) of the Act. Commencement of Regulations 8. These Regulations shall come into operation on the date of publication. MOTSOALEDI, MP NISTER OF HEALTH DATE: I

STAATSKOERANT, 19 SEPTEMBER 2014 No. 38000 13 ANNEXURES FORM A DEPARTMENT OF HEALTH APPLICATION FOR MINISTERIAL CONSENT FOR NON-THERAPEUTIC RESEARCH WITH MINORS 1 INSTRUCTIONS 1.1 This application form must be completed for all protocols that are classified as "non-therapeutic" and involve the participation of minors. Non therapeutic research is defined in the regulations relating to research on human participants as "research that does not hold out the prospect of direct benefit but holds out the prospect of generalizable knowledge". Minors are defined as persons under the age of 18 by Section17 of the Children's Act, 2005 (Act No. 38 of 2005). 1.2 This application form should be submitted with a copy of the protocol and supporting documents. 1.3 This application should be submitted to the Minister of Health or the delegated authority in terms of Section 92(a) of the Act. 1.4 This application form should describe how 'non-therapeutic' research protocols with minors meet the conditions set out in Section 71 (3) of the Act (described below). 1.5 All sections of the form must be completed in full. 1.6 Ministerial Consent may be granted for non-therapeutic health research with minors when certain conditions set out in Section 71 (3) of the Act are met and these conditions are:

14 No. 38000 GOVERNMENT GAZETTE, 19 SEPTEMBER 2014 (a) The research objectives cannot be achieved except by the enrolment of minors; The research is likely to lead to an improved scientific understanding of conditions, or disorders affecting children; (c) Any consent given to the research must be in line with public policy; and (d) The research does not pose a significant risk to minors, and if there is some risk, the benefit of the research outweighs the risk. 2. INVESTIGATORS' DETAILS Name of principal investigator Title of research protocol Institutional affiliation Postal Address Physical Address Email Address Phone Fax Date of Application Signature of Applicant

STAATSKOERANT, 19 SEPTEMBER 2014 No. 38000 15 3. APPLICATION 3.1 Condition 1: The research objectives cannot be achieved except by the participation of minors Describe the scientific justification for the enrolment of minors. Explain why this research must be done with minors as participants: 3.2 Condition 2: The research is likely lead to an improved scientific understanding of certain conditions, diseases or disorders affecting minors Describe how the research might, or aims to, advance knowledge affecting the health and welfare of minors as a class. Note that 'condition' is defined in the Regulations as 'physical and psycho-social characteristics understood to affect health' allowing that this research does not only involve children with an illness. 3.3 Condition 3: Any consent given to the research is in line with public policy Consent given by authorised persons must be in line with public policy considerations. Describe how consent to the research will be in line with public policy or would be acceptable, for example, show how the research poses acceptable risks and promotes the rights of minors:

16 No. 38000 GOVERNMENT GAZETTE, 19 SEPTEMBER 2014 3.4 Condition 4: The research does not pose a significant risk to minors; and if there is some risk, the benefit of the research outweighs the risk. Describe how the potential risks from the research procedures and/or intervention to minor participants will be minimized and describe any possible benefits from the research to society in the form of knowledge: Printed by and obtainable from the Government Printer, Bosman Street, Private Bag X85, Pretoria, 0001 Publications: Tel: (012) 748 6052, 748 6053, 748 6058 Advertisements: Tel: (012) 748 6205, 748 6208, 748 6209, 748 6210, 748 6211 Subscriptions: Tel: (012) 748 6054, 748 6055, 748 6057 Gedruk deur en verkrygbaar by die Staatsdrukker, Bosmanstraat, Privaatsak X85, Pretoria, 0001 Publikasies: Tel: (012) 748 6052, 748 6053, 748 6058 Advertensies: Tel: (012) 748 6205, 748 6208, 748 6209, 748 6210, 748 6211 Subskripsies: Tel: (012) 748 6054, 748 6055, 748 6057 38000 1